Skip to content
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Menu
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Menu
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT

Welcome to the Albert Labs Investor Portal

betterdocs-category-icon

1. Business Plan

9
  • 1.0 Executive Summary
  • 1.1 Corporate Presentation
  • 1.2 Our Market Opportunity
  • 1.3 Psychedelic Therapy
  • 1.4 Science / Clinical Evidence
  • 1.5 Financial Proformas
  • 1.6 Real World Evidence Strategy
  • 1.7 Lab Facilities & Supply Chain
  • 1.8 Further Scientific Literature
betterdocs-category-icon

2. Key Personnel

5
  • 2.1 Board of Directors
  • 2.2 RWE Managerial Team
  • 2.3 Clinical Advisory Board
  • 2.4 R&D Lab Managerial Team
  • 2.5 Scientific Advisory Board
betterdocs-category-icon

3. Corporate Structure

2
  • 3.1 Legal Documents
  • 3.2 Capitalization Table
betterdocs-category-icon

4. Investor Relation Plan

2
  • 4.1 Investor Relations Schedule
  • 4.2 Marketing & Communication Schedule
  • Home
  • Investor Portal
  • 1.8 Further Scientific Literature

1.8 Further Scientific Literature

Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis #

Alexander B. Belser, Gabrielle Agin-Liebes, T. Cody Swift, Sara Terrana, Neşe Devenot, Harris L. Friedman, Jeffrey Guss, Anthony Bossis, and Stephen Ross

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression #

Leor Roseman, David J. Nutt and Robin L. Carhart-Harris

The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act #

Matthew W. Johnson, Roland R. Griffiths a, b, Peter S. Hendricks c, Jack E. Henningfield

Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population #

Peter S Hendricks, Christopher B Thorne, C Brendan Clark, David W Coombs and Matthew W Johnson

Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy #

Tara C. Malone , Sarah E. Mennenga , Jeffrey Guss , Samantha K. Podrebarac , Lindsey T. Owens , Anthony P. Bossis , Alexander B. Belser , Gabrielle Agin-Liebes3, Michael P. Bogenschutz and Stephen Ross,

Invest now

Still want to know more?

Updated on November 1, 2022

1.7 Lab Facilities & Supply Chain

Innovative mental health medicines for patients with unmet needs

  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy
  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy

© 2024 Albert Labs. All Rights Reserved

×

Table of Contents

    • About
    • Clinical Trials
    • Training
    • KRN-101
    • Investing
    • Contact
    • About
    • Clinical Trials
    • Training
    • KRN-101
    • Investing
    • Contact
    Twitter Linkedin Youtube Envelope
    CSE:ABRT
    FSE: VB50
    CSE:ABRT
    FSE: VB50

    About Albert Labs

    We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.

    If you would like support or more information around making an investment, please contact [email protected]

    Twitter Linkedin Youtube Envelope

    Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.

    • This field is for validation purposes and should be left unchanged.
    Twitter
    Youtube
    Linkedin
    Instagram
    Envelope
    Twitter
    Youtube
    Linkedin
    Instagram
    Envelope

    By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok